Pancreatic Islets in Mice with the Obese-hyperglycemic Syndrome: Lack of Effect of Carbutamide
Pancreatic Islets in Mice with the Obese-hyperglycemic Syndrome: Lack of Effect of Carbutamide
复制标题
肥胖高血糖综合征小鼠的胰岛:卡丁酰胺缺乏作用
作者:
W. Gepts;Brussels Jean Christophe;J. Mayer
The hereditary obese-hyperglycemic syndrome is a Mendelian recessive condition which has been intensively studied in the last few years. In particular, mice with this syndrome are grossly obese (weights up to 115 gm. have been recorded), hypercholesterolemic, show high blood glucose levels generally further increased by the administration of growth hormone, an increased lipogenesis even when fasted, increased glycogen turnover, increased liver phosphorylase,* and a number of other nutritional, endocrine and behavioral idiosyncrasies. Of particular interest from the etiological point of view is the fact that the islets of Langerhans are grossly hypertrophied," that the insulin content of the pancreas is increased, that the insulin-like activity of their serum is greater than that of the nonobese animals, that diethyldithiocarbamate, which Kadota and Midorikawa found to be alphacytotoxic, decreases blood sugar and eliminates the hyperglycemic reaction to growth hormone and that the pancreatic glucagon content appears increased after growth hormone administration. It has also been found that carbutamide did not correct the defects in carbohydrate metabolism and in fat metabolism found in these animals.